Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Natane T. Lopes"'
Publikováno v:
International Journal of Dermatology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fec33f4a4e5fe70f96878993af6ed88f
https://doi.org/10.1111/ijd.15316
https://doi.org/10.1111/ijd.15316
Autor:
Felipe Francisco Tuon, Maura Salaroli de Oliveira, Douglas E. Cardoso, Marcos Toshiyuki Tanita, Maria Helena Rigatto, Alexandre P. Zavascki, Anna S. Levin, Diego R. Falci, Claudia Maria Dantas de Maio Carrilho, Lauro Perdigão-Neto, Natane T. Lopes
Publikováno v:
Antimicrobial Agents and Chemotherapy. 60:2443-2449
Nephrotoxicity is the main adverse effect of colistin and polymyxin B (PMB). It is not clear whether these two antibiotics are associated with different nephrotoxicity rates. We compared the incidences of renal failure (RF) in patients treated with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c94a6e34538c7642c9cdc20f89ca2bd
https://doi.org/10.1128/aac.02634-15
https://doi.org/10.1128/aac.02634-15
Publikováno v:
International journal of antimicrobial agents. 47(2)
There are no clinical data for polymyxin B (PMB) in patients on renal replacement therapy (RRT). The aim of this study was to evaluate the characteristics of patients on RRT receiving PMB and to identify predictors of 30-day mortality, with special f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77b71e6b834beec147d2c7ed759ba85b
https://pubmed.ncbi.nlm.nih.gov/26742727
https://pubmed.ncbi.nlm.nih.gov/26742727
Autor:
Laura Czekster Antochevis, Maria Helena Rigatto, Fabiane Jamono Vieira, Alexandre P. Zavascki, Tainá F. Behle, Natane T. Lopes
Publikováno v:
Antimicrobial agents and chemotherapy. 59(10)
There is no clinical evidence supporting the use of polymyxin B in combination with another antimicrobial for infections caused by extensively drug-resistant Acinetobacter baumannii or Pseudomonas aeruginosa isolates. We developed a cohort study of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8682248b9d5665286a3efa8ee8778c0b
https://pubmed.ncbi.nlm.nih.gov/26259799
https://pubmed.ncbi.nlm.nih.gov/26259799
Autor:
Thiela Freitas, Tainá F. Behle, Natane T. Lopes, Maria Helena Rigatto, Diego R. Falci, Leonardo W. Costa, Alexandre P. Zavascki, Maria das Graças Volpe Nunes
Publikováno v:
The Journal of antimicrobial chemotherapy. 70(5)
Objectives The objectives of this study were to assess risk factors for acute kidney injury (AKI) in patients treated with polymyxin B, a last resort antibiotic against Gram-negative bacteria, with a focus on dose, and to determine the impact of AKI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f040abe5b0f65a7e51deab71bd91b25c
https://pubmed.ncbi.nlm.nih.gov/25604744
https://pubmed.ncbi.nlm.nih.gov/25604744